Research Library

A survey of Houston area high school students finds the highest levels of depression occur among older students and transgender youth. This issue brief from the Child Health Policy Program explains how demographic factors affect survey outcomes, noting that school absenteeism and behavioral issues are also associated with students’ poor mental health.

David R. Brockman and Edward M. Emmett discuss three high-profile bills introduced by Texas lawmakers in 2023 and their connection to a broader movement that seeks to privilege Christianity in public schools.

Over half of all Americans live in a state where cannabis is legalized. And yet, the federal government has not reclassified marijuana since 1970. According to the Controlled Substances Act, it is considered a “Schedule 1” substance — the same classification as heroin and crack cocaine with no accepted medical use.

As U.S. democratic principles are being challenged, The Carter Center and Baker Institute for Public Policy have proposed guiding principles to ensure elections are conducted in ways that give Americans greater confidence in their outcomes. This episode explores American elections and how a set of commonsense principles can promote access, security, and confidence.

What if we could bridge the gap between science and practice to help adolescents transform their lives? Nonresident fellows Lilian Dindo and Jan Lindsay share a plan to expand mental health access, strengthen parity, and promote the well-being of young people post COVID-19.

In the fight against Mexican criminal cartels, social network analysis can predict and map out their alliances and subgroups — using algorithms to predict new connections. In this commentary, Nonresident Scholar in Drug Policy and Mexico Studies Nathan P. Jones and his co-authors outline their recent work in the field.

Texas Attorney General Ken Paxton is facing a historic impeachment trial in the state Senate. Fellows Mark Jones and Ed Emmett unpack the issues and make predictions regarding the trial in this episode of Baker Briefing.

This week, the White House announced a new initiative to tackle the growing use of fentanyl laced with xylazine — known to many as "tranq." This combination of drugs poses an alarming and significant threat to public health.